(Q33758811)

29 July 2017

1 reference

title

Non steroidal anti-inflammatory drugs and colorectal cancer: is there a way forward? (English)

1 reference

29 July 2017

1 reference

1 reference

Kubba AK

1

1 reference

29 July 2017

1 June 1999

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

35

1 reference

29 July 2017

892-901

1 reference

29 July 2017

6

1 reference

Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sulindac for polyposis of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aberrant crypt foci of the colon as precursors of adenoma and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Nonsteroidal antiinflammatory drugs and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin use, cancer, and polyps of the large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

NSAID use and decreased risk of gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin use and incidence of large-bowel cancer in a California retirement community

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Low-dose aspirin and incidence of colorectal tumors in a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

APC mutations occur early during colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sulindac suppresses tumorigenesis in the Min mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sulindac metabolism: the importance of an intact colon

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Enhancement of carcinogenesis by prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Subversion of immune system by tumor cells and role of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Aspirin use and potential mechanisms for colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

COX-2 inhibitors for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Prostaglandin E2 down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Inhibition of TNF-induced apoptosis by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900054-4

7 January 2021

10.1016/S0959-8049(99)00054-4

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10533468